{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:03:59Z","timestamp":1777125839269,"version":"3.51.4"},"reference-count":26,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>An antimicrobial resistance (AMR) Action Plan was launched in 2016 to prevent the spread of antimicrobial-resistant bacteria in Japan. Additional support for the appropriate use of pediatric antimicrobial agents was initiated in 2018 to promote the appropriate use of antimicrobial agents in the community. To evaluate the effectiveness of the AMR Action Plan in the community, we investigated antimicrobial prescriptions in community pharmacies. Data on prescriptions for antimicrobial agents dispensed in 42 community pharmacies located in the Tama district, Tokyo, Japan, were collected between April 2013 and December 2019. In this study, we employed the DPY, which was calculated as defined daily doses (DDDs)\/1000 prescriptions\/year. The DPY is the number of antimicrobial agents used (potency) per 1000 antimicrobial prescriptions dispensed in pharmacies per year. The number of prescriptions for third-generation cephalosporins, fluoroquinolones, and macrolides decreased after the initiation of the AMR Action Plan; the DPYs of these antimicrobial agents decreased significantly by 31.4%, increased by 15.8%, and decreased by 23.6%, respectively (p &lt; 0.05). The number of antimicrobial prescriptions for pediatric patients has been decreasing since 2018. Declines in the DPYs of third-generation cephalosporins, fluoroquinolones, and macrolides were higher in pediatric pharmacies than in other pharmacies. Our data suggest that the AMR Action Plan and additional support for the appropriate use of antimicrobial agents in children influenced the number of antimicrobial prescriptions in community pharmacies in Japan.<\/jats:p>","DOI":"10.3390\/antibiotics12081325","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T10:15:48Z","timestamp":1692267348000},"page":"1325","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Surveillance of Antimicrobial Prescriptions in Community Pharmacies Located in Tokyo, Japan"],"prefix":"10.3390","volume":"12","author":[{"given":"Kosuke","family":"Hasegawa","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan"},{"name":"MEDIX, Inc. 1-2-3 Motoyokoyamacho, Hachioji, Tokyo 192-0063, Japan"},{"name":"Shinwa Pharmacy Minamishincho Store, 13-21 Minamishincho, Hachioji, Tokyo 192-0075, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Mori","sequence":"additional","affiliation":[{"name":"MEDIX, Inc. 1-2-3 Motoyokoyamacho, Hachioji, Tokyo 192-0063, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Asakura","sequence":"additional","affiliation":[{"name":"MEDIX, Inc. 1-2-3 Motoyokoyamacho, Hachioji, Tokyo 192-0063, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Matsumura","sequence":"additional","affiliation":[{"name":"MEDIX, Inc. 1-2-3 Motoyokoyamacho, Hachioji, Tokyo 192-0063, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2889-8257","authenticated-orcid":false,"given":"Hidemasa","family":"Nakaminami","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.35772\/ghm.2020.01005","article-title":"Road to comprehensive estimation of antimicrobial resistance (AMR) disease burden in Japan","volume":"2","author":"Tsuzuki","year":"2020","journal-title":"Glob. Health Med."},{"key":"ref_2","unstructured":"(2022, July 27). Nippon AMR One Health Report (NAOR). Available online: https:\/\/www.mhlw.go.jp\/content\/10900000\/000938734.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1099\/jmm.0.000735","article-title":"Characterization of SCCmec type IV methicillin-resistant Staphylococcus aureus clones increased in Japanese hospitals","volume":"67","author":"Nakaminami","year":"2018","journal-title":"J. Med. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jiac.2018.03.004","article-title":"Change in genotype of methicillin-resistant Staphylococcus aureus (MRSA) affects the antibiogram of hospital-acquired, MRSA","volume":"24","author":"Harada","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s15010-017-1097-x","article-title":"The first report of Japanese antimicrobial use measured by national database based on health insurance claims data (2011\u20132013): Comparison with sales data, and trend analysis stratified by antimicrobial category and age group","volume":"46","author":"Yamasaki","year":"2018","journal-title":"Infection"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2019.11.009","article-title":"Indications and classes of outpatient antibiotic prescriptions in Japan: A descriptive study using the national database of electronic health insurance claims, 2012\u20132015","volume":"91","author":"Hashimoto","year":"2020","journal-title":"Int. J. Infect.Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kimura, Y., Fukuda, H., Hayakawa, K., Ide, S., Ota, M., Saito, S., Ishikane, M., Kusama, Y., Matsunaga, N., and Ohmagari, N. (2019). Longitudinal trends of and factors associated with inappropriate antibiotic prescribing for non-bacterial acute respiratory tract infection in Japan: A retrospective claims database study, 2012\u20132017. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223835"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jiac.2021.07.001","article-title":"Trends and patterns in antibiotic prescribing for adult outpatients with acute upper respiratory tract infection in Japan, 2008\u20132018","volume":"27","author":"Ji","year":"2021","journal-title":"J. Infect. Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1001\/jama.2017.18715","article-title":"Association of Broad- vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract Infections","volume":"318","author":"Gerber","year":"2017","journal-title":"JAMA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijid.2020.11.158","article-title":"The effects of Japan\u2019s National Action Plan on Antimicrobial Resistance on antimicrobial use","volume":"103","author":"Kusama","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Gu, Y., Fujitomo, Y., and Ohmagari, N. (2021). Outcomes and Future Prospect of Japan\u2019s National Action Plan on Antimicrobial Resistance (2016\u20132020). Antibiotics, 10.","DOI":"10.3390\/antibiotics10111293"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Muraki, Y., Maeda, M., Inose, R., Yoshimura, K., Onizuka, N., Takahashi, M., Kawakami, E., Shikamura, Y., Son, N., and Iwashita, M. (2022). Exploration of Trends in Antimicrobial Use and Their Determinants Based on Dispensing Information Collected from Pharmacies throughout Japan: A First Report. Antibiotics, 11.","DOI":"10.3390\/antibiotics11050682"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jgar.2016.07.002","article-title":"Japanese antimicrobial consumption surveillance: First report on oral and parenteral antimicrobial consumption in Japan (2009\u20132013)","volume":"7","author":"Muraki","year":"2016","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jiac.2018.01.003","article-title":"Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016","volume":"24","author":"Tsutsui","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"ref_15","unstructured":"(2023, July 18). Statistics Department BoGA, Tokyo Metropolitan Government. Available online: https:\/\/www.toukei.metro.tokyo.lg.jp\/."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1016\/j.sapharm.2021.09.003","article-title":"Clinical factors associated with increased length of stay and readmission in patients with medication-related hospital admissions: A retrospective study","volume":"18","author":"Wojt","year":"2022","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kusama, Y., Muraki, Y., Tanaka, C., Koizumi, R., Ishikane, M., Yamasaki, D., Tanabe, M., and Ohmagari, N. (2021). Characteristics and limitations of national antimicrobial surveillance according to sales and claims data. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0251299"},{"key":"ref_18","unstructured":"(2022, March 25). DUVAT (Drug Use Visualization Assisting Tool). Available online: https:\/\/kpu-cpe.sakura.ne.jp\/duvathp\/index.html."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Muraki, Y., Kusama, Y., Tanabe, M., Hayakawa, K., Gu, Y., Ishikane, M., Yamasaki, D., Yagi, T., and Ohmagari, N. (2020). Impact of antimicrobial stewardship fee on prescribing for Japanese pediatric patients with upper respiratory infections. BMC Health Serv. Res., 20.","DOI":"10.1186\/s12913-020-05288-1"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/ije\/dyac057","article-title":"The consequence of financial incentives for not prescribing antibiotics: A Japan\u2019s nationwide quasi-experiment","volume":"51","author":"Okubo","year":"2022","journal-title":"Int. J. Epidemiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.anl.2020.05.019","article-title":"Clinical practice guidelines for the diagnosis and management of acute otitis media in children-2018 update","volume":"47","author":"Hayashi","year":"2020","journal-title":"Auris Nasus Larynx"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.prrv.2005.06.005","article-title":"Macrolides and airway inflammation in children","volume":"6","author":"Shinkai","year":"2005","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41390-021-01613-4","article-title":"Long-term, low-dose macrolide antibiotic treatment in pediatric chronic airway diseases","volume":"91","author":"Sun","year":"2022","journal-title":"Pediatr. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.anl.2015.08.014","article-title":"Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan","volume":"43","author":"Shimizu","year":"2016","journal-title":"Auris Nasus Larynx"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Koizumi, R., Kusama, Y., Muraki, Y., Ishikane, M., Yamasaki, D., Tanabe, M., and Ohmagari, N. (2021). Effect of population inflow and outflow between rural and urban areas on regional antimicrobial use surveillance. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0248338"},{"key":"ref_26","unstructured":"(2023, June 18). National Action Plan on Antimicrobial Resistance (AMR) 2023\u20132027. Available online: https:\/\/www.mhlw.go.jp\/content\/10900000\/001096228.pdf."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/8\/1325\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:35:34Z","timestamp":1760128534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/8\/1325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["antibiotics12081325"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics12081325","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]}}}